We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+22.29%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$238M
AUM Growth
+$18.4M
Cap. Flow
-$9.32M
Cap. Flow %
-3.92%
Top 10 Hldgs %
20.27%
Holding
151
New
51
Increased
24
Reduced
32
Closed
43

Sector Composition

Rank Sector Weight
1 Industrials 19.9%
2 Healthcare 18.54%
3 Consumer Discretionary 15.92%
4 Financials 10.72%
5 Technology 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMGI
76
DELISTED
Wright Medical Group Inc
WMGI
$1.42M 0.6%
+46,145
New +$1.31M
RYL
77
DELISTED
RYLAND GROUP INC
RYL
$1.23M 0.52%
28,235
-9,435
-25% -$374K
TCS
78
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$1.21M 0.51%
+1,737
New +$1.02M
SPNC
79
DELISTED
Spectranetics Corp
SPNC
$1.21M 0.51%
+48,375
New +$1.04M
EFII
80
DELISTED
Electronics for Imaging
EFII
$1.19M 0.5%
+30,590
New +$1.11M
SONC
81
DELISTED
Sonic Corp
SONC
$1.17M 0.49%
58,100
-35,070
-38% -$681K
LGND icon
82
Ligand Pharmaceuticals
LGND
$5.76B
$1.07M 0.45%
+32,501
New +$1.06M
ZGNX
83
DELISTED
Zogenix, Inc.
ZGNX
$1.06M 0.45%
+38,498
New +$863K
EFOR
84
Everforth Inc
EFOR
$1.17B
$1.04M 0.44%
29,935
-28,095
-48% -$936K
ANN
85
DELISTED
ANN INC
ANN
$1.04M 0.44%
28,325
-28,755
-50% -$1.02M
IPHI
86
DELISTED
INPHI CORPORATION
IPHI
$1.03M 0.43%
79,976
-3,739
-4% -$47.8K
ALNY icon
87
Alnylam Pharmaceuticals
ALNY
$27.5B
$974K 0.41%
15,140
-20,384
-57% -$1.22M
ACAD icon
88
Acadia Pharmaceuticals
ACAD
$4.43B
$969K 0.41%
38,760
-27,595
-42% -$651K
BURL icon
89
Burlington
BURL
$23.2B
$939K 0.39%
+29,335
New +$820K
BNFT
90
DELISTED
Benefitfocus, Inc.
BNFT
$862K 0.36%
+14,925
New +$727K
FARO
91
DELISTED
Faro Technologies
FARO
$847K 0.36%
+14,520
New +$721K
HAIN icon
92
Hain Celestial
HAIN
$45M
$770K 0.32%
+16,960
New +$701K
RH icon
93
RH
RH
$3.13B
$761K 0.32%
11,315
-1,795
-14% -$123K
MFRM
94
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
$731K 0.31%
+16,985
New +$607K
CVLT icon
95
Commault Systems
CVLT
$4.88B
$710K 0.3%
9,480
-9,850
-51% -$771K
KFRC icon
96
Kforce
KFRC
$1.02B
$699K 0.29%
+34,140
New +$656K
IPCM
97
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
$671K 0.28%
+11,303
New +$641K
ULTI
98
DELISTED
Ultimate Software Group Inc
ULTI
$579K 0.24%
+3,780
New +$571K
WCIC
99
DELISTED
WCI Communities, Inc.
WCIC
$534K 0.22%
+27,968
New +$510K
TNDM icon
100
Tandem Diabetes Care
TNDM
$1.34B
$501K 0.21%
+1,943
New +$444K

Similar funds

Lisanti Capital Growth's Q4 2013 Portfolio in Review

As of Q4 2013, Lisanti Capital Growth held 151 positions worth $238M, up 8.4% from $219M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lisanti Capital Growth withdrew a net $9.32M in Q4 2013, closing 43 positions and reducing 32 holdings. Its most notable exit was NPS PHARMACEUTICALS INC, an estimated $4.58M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Lisanti Capital Growth opened a new position in NuVasive, Inc. worth $4.39M.

  • Lisanti Capital Growth's largest Q4 2013 buy was NuVasive, Inc.: 135,730 shares worth $4.39M.
  • Lisanti Capital Growth added most to Gentherm in Q4 2013, an estimated $1.99M increase.
  • Lisanti Capital Growth's biggest Q4 2013 reduction was LL Flooring Holdings, Inc., cutting an estimated $3.35M.
  • Lisanti Capital Growth fully exited NPS PHARMACEUTICALS INC in Q4 2013, selling an estimated $4.58M.
  • Lisanti Capital Growth's ten largest holdings make up 20% of its $238M portfolio in Q4 2013.
  • Lisanti Capital Growth opened 51 new positions and closed 43 in Q4 2013.
  • Lisanti Capital Growth's portfolio value rose 8.4% quarter-over-quarter to $238M.

Based on Lisanti Capital Growth's 13F filing for Q4 2013, filed 29 Jan 2014.